Dawn Hill

Dawn Hill is Senior, Vice President of Clinical Operations at Navire and serves in this role at other BridgeBio affiliates, including QED Therapeutics. She brings more than 25 years of experience in clinical trial management, outsourcing and business development.  Prior to joining BridgeBio, she spent seven years as Executive Director of Clinical Operations at OncoMed Pharmaceutics where she provided strategic oversight of multiple early phase oncology trials across 9 different compounds.  Prior to OncoMed, she spent 14 years at a global full service CRO, Omnicare/Clinimetrics, as Vice President, Business Operations where she was responsible for US business development, project delivery and contract management. Early in her career, She also worked in clinical development at Chiron and Syntex Research. She earned a B.S. in Biochemistry from the University of California at Davis.